Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Toxicological Sciences

• Publication date

  2010-02-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/toxsci/kfp275PMID 19915082PMCID PMC2807038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid.

  2009cited by this paper
• Disposition of perfluorinated acid isomers in sprague‐dawley rats; Part 2: Subchronic dose

  2009cited by this paper
• Organic anion transporting polypeptide (Oatp) 1a1-mediated perfluorooctanoate transport and evidence for a renal reabsorption mechanism of Oatp1a1 in renal elimination of perfluorocarboxylates in rats.

  2009cited by this paper
• Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.

  2009cited by this paper
• Comparison of the toxicokinetic behavior of perfluorohexanoic acid (PFHxA) and nonafluorobutane-1-sulfonic acid (PFBS) in cynomolgus monkeys and rats.

  2009cited by this paper
• Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.

  2008cited by this paper
• Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water.

  2008cited by this paper
• Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action.

  2008cited by this paper
• Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis.

  2008cited by this paper
• Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats

  2008cited by this paper
• Production of perfluorinated carboxylic acids (PFCAs) from the biotransformation of polyfluoroalkyl phosphate surfactants (PAPS): exploring routes of human contamination.

  2007cited by this paper
• Rat Organic Anion Transporter 3 and Organic Anion Transporting Polypeptide 1 Mediate Perfluorooctanoic Acid Transport

  2007cited by this paper
• Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers

  2007cited by this paper
• Perfluoroalkyl acids: a review of monitoring and toxicological findings.

  2007cited by this paper
• Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones.

  2007cited by this paper
• Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles

  2007influential reference
• Atmospheric chemistry of N-methyl perfluorobutane sulfonamidoethanol, C4F9SO2N(CH3)CH2CH2OH: kinetics and mechanism of reaction with OH.

  2006cited by this paper
• Formation of C7F15COOH (PFOA) and other perfluorocarboxylic acids during the atmospheric oxidation of 8:2 fluorotelomer alcohol.

  2006cited by this paper
• Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives.

  2006cited by this paper
• Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat.

  2006cited by this paper
• Molecular physiology of renal organic anion transporters.

  2006cited by this paper
• Functional Characterization of Rat Organic Anion Transporter 5 (Slc22a19) at the Apical Membrane of Renal Proximal Tubules

  2005cited by this paper
• Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney.

  2004cited by this paper
• Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition.

  2004influential reference
• Perspective on fluorocarbon chemistry.

  2004cited by this paper
• The Toxicology of Perfluorooctanoate

  2004cited by this paper
• Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys.

  2004cited by this paper
• Human Organic Anion Transporter 3 (hOAT3) can Operate as an Exchanger and Mediate Secretory Urate Flux

  2003cited by this paper
• Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient.

  2003cited by this paper
• Binding of perfluorooctanoic acid to rat and human plasma proteins.

  2003cited by this paper
• The superfamily of organic anion transporting polypeptides.

  2003cited by this paper
• Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

  2003cited by this paper
• Sex hormone-regulated renal transport of perfluorooctanoic acid.

  2002cited by this paper
• Sex differences in p-aminohippuric acid transport in rat kidney: Role of membrane fluidity and expression of OAT1

  2002influential reference
• Gender Difference in the Urinary Excretion of Organic Anions in Rats

  2002cited by this paper
• Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney.

  2002influential reference
• Gender-specific and developmental influences on the expression of rat organic anion transporters.

  2002cited by this paper
• The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.

  2002cited by this paper
• Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors.

  2002cited by this paper
• Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats.

  2001influential reference
• Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells.

  1999cited by this paper
• Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney.

  1999influential reference
• Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells.

  1999cited by this paper
• Identification of Glutathione as a Driving Force and Leukotriene C4 as a Substrate for oatp1, the Hepatic Sinusoidal Organic Solute Transporter*

  1998cited by this paper
• Cloning and Characterization of a Novel Multispecific Organic Anion Transporter *

  1997cited by this paper
• Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules.

  1997cited by this paper
• Expression Cloning and Characterization of ROAT1

  1997cited by this paper
• Expression cloning and characterization of a renal organic anion transporter from winter flounder

  1997cited by this paper
• Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter*

  1997cited by this paper
• Immunologic distribution of an organic anion transport protein in rat liver and kidney.

  1996cited by this paper
• Regulation of renal oatp mRNA expression by testosterone.

  1996cited by this paper
• Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats.

  1991cited by this paper

• Widespread PFAS Contamination in Pet Food: Dietary Sources and Health Risks to Companion Animals.

  2026cites this paper
• Development of a physiologically based pharmacokinetic model to improve risk assessment of 6:2 Chlorinated polyfluoroalkyl ether sulfonate on human health.

  2026cites this paper
• Age disparities in PFAS-associated influenza-like illness among adult females at low exposure levels.

  2026cites this paper
• Biological pathways of per- and polyfluoroalkyl substances (PFAS): A critical review of cellular and molecular toxicity mechanisms.

  2026cites this paper
• Investigating the quantitative toxicological relationship between PFAS alkyl fluorine structure and exposure levels leading to changes in blood-based clinical markers in rats

  2025cites this paper
• Understanding Mechanisms of PFAS Absorption, Distribution, and Elimination Using a Physiologically Based Toxicokinetic Model.

  2025cites this paper
• Longitudinal and cross-sectional analysis of perfluoroalkyl substances and kidney function

  2025cites this paper
• Binding of per- and polyfluoroalkyl substances with liver and serum proteins in rats: implications for physiologically based pharmacokinetic modelling.

  2025cites this paper
• Perfluoroalkane Sulfonamides and Derivatives, a Different Class of PFAS: Sorption and Microbial Biotransformation Insights

  2025cites this paper
• Per- and polyfluoroalkyl substances (PFAS): immunotoxicity at the primary sites of exposure

  2025cites this paper
• Perfluorooctane sulfonate (PFOS) exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model.

  2025cites this paper
• Bioaccumulation and Uptake Kinetics of Per- and Polyfluoroalkyl Substances in Pimephales promelas.

  2025cites this paper
• Preconception exposure to perfluorooctanesulfonic acid (PFOS) and perfluorobutanesulfonic acid (PFBS) impaired reproduction via insulin/insulin-like growth factor signaling pathway without effects on the second generation in Caenorhabditis elegans

  2025cites this paper
• Bioconcentration, maternal transfer, and toxicokinetics of PFOS in a multi-generational zebrafish exposure

  2025cites this paper
• High-throughput screening of protein interactions with per- and polyfluoroalkyl substances (PFAS) used in photolithography.

  2025cites this paper
• Functional and Transcriptional Disruption of Hepatic ABC Transporters by Environmentally Relevant Short‐Chain Per‐ and Polyfluoroalkyl Substances (PFAS)

  2025cites this paper
• Neurotoxicity and Potential Mechanisms of Exposure to Per- and Polyfluoroalkyl Substances (PFASs)

  2025cites this paper
• Long-term impact of per- and polyfluoroalkyl substances on kidney health: a large-scale genetic study

  2025cites this paper
• Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice

  2024cites this paper
• Clinical, histological, molecular, and toxicokinetic renal outcomes of per-/polyfluoroalkyl substances (PFAS) exposure: Systematic review and meta-analysis.

  2024cites this paper
• Kinetics of 15 per- and polyfluoroalkyl substances (PFAS) after single oral application as a mixture - A pilot investigation in a male volunteer.

  2024cites this paper
• In vitro and in silico characterization of the transport of selected perfluoroalkyl carboxylic acids and perfluoroalkyl sulfonic acids by human organic anion transporter 1 (OAT1), OAT2 and OAT3.

  2024cites this paper
• In Vitro Hepatic Clearance Evaluations of Per- and Polyfluoroalkyl Substances (PFAS) across Multiple Structural Categories

  2024cites this paper
• Associations between co-exposure to per- and polyfluoroalkyl substances and metabolic diseases: The mediating roles of inflammation and oxidative stress.

  2024cites this paper
• Unbound Fractions of PFAS in Human and Rodent Tissues: Rat Liver a Suitable Proxy for Evaluating Emerging PFAS?

  2024cites this paper
• An In-depth Examination of Per- and Polyfluoroalkyl (PFAS) Effects on Transporters, with Emphasis on the ABC Superfamily: A Critical Review.

  2024cites this paper
• Evaluation of 14 PFAS for Permeability and Organic Anion Transporter Interactions: Implications for Renal Clearance in Humans.

  2024cites this paper
• Species-Specific Unbound Fraction Differences in Highly Bound PFAS: A Comparative Study across Human, Rat, and Mouse Plasma and Albumin

  2024cites this paper
• Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice.

  2024cites this paper
• Perfluorooctanoic acid (PFOA) exposure in relation to the kidneys: A review of current available literature

  2023cites this paper
• Exploring Route-Specific Pharmacokinetics of PFAS in Mice by Coupling in Vivo Tests and Physiologically Based Toxicokinetic Models

  2023cites this paper
• Evaluating the toxicokinetics of some metabolites of a C6 polyfluorinated compound, 6:2 fluorotelomer alcohol in pregnant and nonpregnant rats after oral exposure to the parent compound.

  2023cites this paper
• Elevated Maternal Testosterone Levels Alter PFOA Elimination and Tissue Distribution in Pregnant Rats.

  2023cites this paper
• Role of Salinity in Perfluorooctane Sulfonate (PFOS) Bioconcentration between Aquatic Species and the Differential Regulation of Transporters in Fundulus Heteroclitus

  2023cites this paper
• A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics

  2023cites this paper
• Effect of dietary antioxidants on excretion of perfluorooctanoic acid (PFOA) via regulating uptake transporters expression and intestinal permeability in mice.

  2023cites this paper
• Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes.

  2023cites this paper
• Probing the Interactions of Perfluorocarboxylic Acids of Various Chain Lengths with Human Serum Albumin: Calorimetric and Spectroscopic Investigations.

  2023cites this paper
• Emerging and Legacy Perfluoroalkyl Substances in Breastfed Chinese Infants: Renal Clearance, Body Burden, and Implications

  2023cites this paper
• Evaluation of Per- and Polyfluoroalkyl Substances (PFAS) In Vitro Toxicity Testing for Developmental Neurotoxicity.

  2023cites this paper
• A Scoping Assessment of Implemented Toxicokinetic Models of Per- and Polyfluoro-Alkyl Substances, with a Focus on One-Compartment Models

  2023cites this paper
• Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)

  2022cites this paper
• Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat

  2022cites this paper
• The Need for Testing Isomer Profiles of Perfluoroalkyl Substances to Evaluate Treatment Processes

  2022cites this paper
• Truth in the Serum? Estimating PFAS Relative Potency for Human Risk Assessment

  2022cites this paper
• Toxicokinetic Modeling of Per- and Polyfluoroalkyl Substance Concentrations within Developing Zebrafish (Danio rerio) Populations

  2022cites this paper
• Lack of interaction of the fluorosurfactant C6O4 with human renal transporters: in vitro/in silico analysis.

  2022cites this paper
• A food web bioaccumulation model for the accumulation of per- and polyfluoroalkyl substances (PFAS) in fish: how important is renal elimination?

  2022cites this paper
• IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making

  2022cites this paper
• Exposure of Preconception Couples to Legacy and Emerging Per- and Polyfluoroalkyl Substances: Variations Within and Between Couples.

  2022cites this paper
• Review of per- and polyfluoroalkyl substances (PFAS) bioaccumulation in earthworms

  2022cites this paper
• The role of OATP1A1 in cholestasis and drug-induced toxicity: a systematic review

  2022cites this paper
• Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values

  2021cites this paper
• Endocrine Disruptor Potential of Short- and Long-Chain Perfluoroalkyl Substances (PFASs)—A Synthesis of Current Knowledge with Proposal of Molecular Mechanism

  2021cites this paper
• Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.

  2021cites this paper
• Integrative Computational Approaches to Inform Relative Bioaccumulation Potential of per- and Polyfluoroalkyl Substances (PFAS) across Species.

  2021cites this paper
• Understanding the dynamics of physiological changes, protein expression, and PFAS in wildlife.

  2021cites this paper
• Perfluorooctane sulfonate (PFOS) induces several behavioural defects in Caenorhabditis elegans that can also be transferred to the next generations.

  2021cites this paper
• Perfluoroalkyl Carboxylic Acids Interact with the Human Bile Acid Transporter NTCP

  2021cites this paper
• Half-lives of several polyfluoroalkyl substances (PFAS) in cattle serum and tissues

  2021cites this paper
• Bayesian Refinement of the Permeability-Limited Physiologically Based Pharmacokinetic Model for Perfluorooctanoic Acid in Male Rats.

  2021cites this paper
• Absorption, distribution, and toxicity of per- and polyfluoroalkyl substances (PFAS) in the brain: a review.

  2021cites this paper
• Addressing Urgent Questions for PFAS in the 21st Century.

  2021cites this paper
• A Roadmap to the Structure-Related Metabolism Pathways of Per- and Polyfluoroalkyl Substances in the Early Life Stages of Zebrafish (Danio rerio)

  2021cites this paper
• Biomarkers of poly- and perfluoroalkyl substances (PFAS) in Sub-Arctic and Arctic communities in Canada.

  2021cites this paper
• Perfluorooctanesulfonic acid (PFOS) thwarts the beneficial effects of calorie restriction and Metformin.

  2021cites this paper
• Toxicokinetics of perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) in male and female Hsd:Sprague dawley SD rats following intravenous or gavage administration

  2020cites this paper
• Impacts of Sex and Exposure Duration on Gene Expression in Zebrafish Following Perfluorooctane Sulfonate Exposure

  2020cites this paper
• Characterizing biopersistence potential of the metabolite 5:3 fluorotelomer carboxylic acid after repeated oral exposure to the 6:2 fluorotelomer alcohol.

  2020cites this paper
• Serum concentrations of perfluorinated alkyl substances in farmers living in areas affected by water contamination in the Veneto Region (Northern Italy).

  2020cites this paper
• Perfluoroalkyl chemicals in neurological health and disease: Human concerns and animal models.

  2020cites this paper
• Gender differences in pharmacokinetics of perfluoropentanoic acid using non-linear mixed-effect modeling in rats

  2020cites this paper
• A Pathology Review of the Lower Gastrointestinal Tract in Relation to Ulcerative Colitis in Rats and Cynomolgus Macaques Treated With Ammonium Perfluorooctanoate

  2020cites this paper
• Membrane/water partitioning and permeabilities of perfluoroalkyl acids and four of their alternatives and the effects on toxicokinetic behavior.

  2020cites this paper
• Serum Half-Lives for Short- and Long-Chain Perfluoroalkyl Acids after Ceasing Exposure from Drinking Water Contaminated by Firefighting Foam

  2020cites this paper
• Perfluorooctanesulfonic acid (PFOS) and perfluorobutanesulfonic acid (PFBS) impaired reproduction and altered offspring physiological functions in Caenorhabditis elegans.

  2020cites this paper
• Effects of perfluoroalkyl carboxylic acids on the uptake of sulfobromophthalein via organic anion transporting polypeptides in human intestinal Caco-2 cells

  2020cites this paper
• Chemical Characterization of a Legacy Aqueous Film-Forming Foam Sample and Developmental Toxicity in Zebrafish (Danio rerio)

  2020cites this paper
• Risk to human health related to the presence of perfluoroalkyl substances in food

  2020cites this paper
• Per‐ and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

  2020cites this paper
• PFAS Exposure Pathways for Humans and Wildlife: A Synthesis of Current Knowledge and Key Gaps in Understanding

  2020cites this paper
• Estimating the Equilibrium Distribution of Perfluoroalkyl Acids and 4 of Their Alternatives in Mammals

  2020influential citation
• Assessing the human health risks of per- and polyfluoroalkyl substances: A need for greater focus on their interactions as mixtures.

  2020cites this paper
• Toxicology and carcinogenesis studies of perfluorooctanoic acid administered in feed to Sprague Dawley (Hsd:Sprague Dawley SD) rats.

  2020cites this paper
• Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.

  2019cites this paper
• Phospholipid Levels Predict the Tissue Distribution of Poly- and Perfluoroalkyl Substances in a Marine Mammal.

  2019cites this paper
• Children's exposure to perfluoroalkyl acids - a modelling approach.

  2019cites this paper
• Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.

  2019cites this paper
• Perfluoroalkyl substances and bone health in young men: a pilot study

  2019cites this paper
• Subtle morphometric, behavioral and gene expression effects in larval zebrafish exposed to PFHxA, PFHxS and 6:2 FTOH.

  2019cites this paper
• Probing the Differential Tissue Distribution and Bioaccumulation Behavior of Per- and Polyfluoroalkyl Substances of Varying Chain-Lengths, Isomeric Structures and Functional Groups in Crucian Carp.

  2018cites this paper
• Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish.

  2018cites this paper
• Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives.

  2018cites this paper
• Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model

  2018cites this paper
• Internal exposure-based pharmacokinetic evaluation of potential for biopersistence of 6:2 fluorotelomer alcohol (FTOH) and its metabolites.

  2018cites this paper
• Perfluoroalkyl Substances in the Environment

  2018cites this paper
• Relationship between peroxisome proliferator‐activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells

  2018cites this paper
• Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

  2018cites this paper
• Low molecular weight PFAS alternatives (c-6) result in fewer cellular and behavioral alterations than long chain (c-8/c-9) PFASs in larval zebrafish

  2018cites this paper
• Impact of perfluorochemicals on human health and reproduction: a male’s perspective

  2018cites this paper